Literature DB >> 9703170

Reversal of hypoaesthesia by nerve block, or placebo: a psychologically mediated sign in chronic pseudoneuropathic pain patients.

R J Verdugo1, J L Ochoa.   

Abstract

OBJECTIVES: To gain understanding of the mechanism and meaning of improvement of hypoaesthesia after a diagnostic intervention, and of the nature of the population that displays such a sign.
METHODS: Patients with chronic "neuropathic" pain underwent rigorous clinical and laboratory investigations, including placebo controlled local anaesthetic block. Patients displaying profound regional cutaneous hypoaesthesia and pain entered the study through either of two criteria: (a) reversal of hypoaesthesia after diagnostic block, (b) nerve injury as the cause of hypoaesthesia and pain. The semeiology displayed by these patients together with the behaviour of their sensory phenomena in response to blocks were compared. Three groups were expected: (1) patients with "neuropathic" pain with profound hypoaesthesia reversed by block, but without neuropathy; (2) patients whose hypoaesthesia did not reverse and who had neuropathy as the cause of their sensory dysfunction; and (3) patients whose hypoaesthesia reversed, and had neuropathy.
RESULTS: Two groups emerged: (1) patients with profound hypoaesthesia reversed by block, but without neuropathy (27 patients), and (2) patients whose hypoaesthesia did not reverse and who had a neuropathy (13 patients). No patient with neuropathy was found whose cutaneous hypoaesthesia improved with block. The first group displayed the sensory-motor characteristics of psychogenic pseudoneuropathy. The semeiology of the second group was in keeping with organic neuropathy and displayed no pseudoneurological features. Spontaneous pain was relieved by placebo in 66.6% of the patients in groupl and 53.8% in group 2.
CONCLUSIONS: Such reversal of hypoaesthesia is due to a placebo effect, acting on a psychogenic symptom because: (a) 27 of 27 patients in which the sign occurred had absence of nerve disease behind the "neuropathic" symptoms, (b) In 26 of 27 patients the area of hypoaesthesia was non-anatomical, (c) 16 of 27 patients had other sensory-motor signs that could not be explained as a result of organic pathology (give way weakness and punctual denial of hypoaesthesia), and (d) the phenomenon was not found in patients with organic neuropathy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9703170      PMCID: PMC2170207          DOI: 10.1136/jnnp.65.2.196

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  29 in total

1.  Medical modification of sensation.

Authors:  C J Hodge; R B King
Journal:  J Neurosurg       Date:  1976-01       Impact factor: 5.115

2.  Lidocaine test in neuralgia.

Authors:  Paolo Marchettini; Marco Lacerenza; Claudio Marangoni; Giulio Pellegata; Maria Luisa Sotgiu; Salvatore Smirne
Journal:  Pain       Date:  1992-03       Impact factor: 6.961

3.  Essence, investigation, and management of "neuropathic" pains: hopes from acknowledgment of chaos.

Authors:  J L Ochoa
Journal:  Muscle Nerve       Date:  1993-10       Impact factor: 3.217

4.  Sucker-punched again! Physicians meet the disease-of-the-month syndrome.

Authors:  E Shorter
Journal:  J Psychosom Res       Date:  1995-02       Impact factor: 3.006

5.  Regional pain is usually hysterical.

Authors:  M I Weintraub
Journal:  Arch Neurol       Date:  1988-08

Review 6.  Pain mechanisms in neuropathy.

Authors:  J L Ochoa
Journal:  Curr Opin Neurol       Date:  1994-10       Impact factor: 5.710

Review 7.  Occupational injury. Fact, fantasy, or fraud?

Authors:  D V Voiss
Journal:  Neurol Clin       Date:  1995-05       Impact factor: 3.806

Review 8.  Use and misuse of conventional electrodiagnosis, quantitative sensory testing, thermography, and nerve blocks in the evaluation of painful neuropathic syndromes.

Authors:  R J Verdugo; J L Ochoa
Journal:  Muscle Nerve       Date:  1993-10       Impact factor: 3.217

9.  Method for quantitative estimation of thermal thresholds in patients.

Authors:  H Fruhstorfer; U Lindblom; W C Schmidt
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-11       Impact factor: 10.154

10.  Engel's "Psychogenic Pain and the Pain-Prone Patient:" a retrospective, controlled clinical study.

Authors:  R H Adler; S Zlot; C Hürny; C Minder
Journal:  Psychosom Med       Date:  1989 Jan-Feb       Impact factor: 4.312

View more
  3 in total

1.  Neuropathic pain syndrome displayed by malingerers.

Authors:  José L Ochoa; Renato J Verdugo
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2010       Impact factor: 2.198

Review 2.  Controversies surrounding reflex sympathetic dystrophy: a review article.

Authors:  R P Pawl
Journal:  Curr Rev Pain       Date:  2000

3.  Randomised controlled trial of gabapentin in Complex Regional Pain Syndrome type 1 [ISRCTN84121379].

Authors:  Anton C van de Vusse; Suzanne G M Stomp-van den Berg; Alfons H F Kessels; Wim E J Weber
Journal:  BMC Neurol       Date:  2004-09-29       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.